Thinking About Buying Wegovy Cheap? Here's What UK Pricing Really Means

What the clinical evidence actually says about Wegovy's cost-to-benefit calculation

NICE's appraisal of semaglutide for weight management, published as TA875, assessed the medicine against a backdrop of meaningful average weight reductions. The pivotal STEP 1 trial, which followed adults with obesity over 68 weeks, reported an average body-weight reduction of around 15% at the 2.4mg maintenance dose. That figure comes from a study of thousands of adults managing obesity without type 2 diabetes, and NICE concluded the medicine offered sufficient benefit to recommend it, but only within a structured specialist service, and for a maximum of two years.

The clinical bar is real, and so is the cost bar. Eli Lilly's well-reported list-price adjustment in September 2025 shifted the market significantly: reported private prices for semaglutide now typically range from roughly £149 to £375 per month depending on dose and provider, according to widespread reporting following the manufacturer's announcement. Those figures are the broadest honest bracket available, individual prices sit somewhere inside it, and dose matters because you start low and titrate upward over months. A fuller breakdown of what affects the monthly figure puts those numbers in context.

What the clinical data also tells you is that results require sustained treatment alongside diet and activity changes. A cheaper monthly price that cuts corners on clinical oversight undermines the very conditions under which the trials demonstrated those outcomes.

What 'headline' Wegovy prices typically leave out

Comparing private Wegovy prices is genuinely tricky because providers build their offers differently. Some list the medicine alone and add a consultation fee separately; others charge for the prescription as a distinct line item; delivery is free at some providers and not at others. Aftercare (the ongoing clinical support that NICE considers integral to safe use) is sometimes described in vague terms and sometimes absent altogether.

That matters for two reasons. First, the total you actually pay can look quite different once everything is added. A lower headline figure with three separate fees attached can land above a single all-in price. Second, clinical follow-up is not optional for a prescription medicine of this type. Dose titration, monitoring for side effects, and the decision about whether to continue beyond six months if progress is limited, all of that requires a prescriber who knows your case. If aftercare is thin or difficult to reach, you are not getting cheap Wegovy; you are getting less medicine than the label suggests. Exploring the genuinely cheapest route means accounting for the full picture, not just the opening price.

One thing worth timing, if payday or a bank holiday is in play: because same-day dispatch at nume depends on orders placed before 12pm Monday to Friday, it is worth ordering on the first working day after any gap rather than hoping a weekend or holiday order moves quickly.

Where nume sits on price, and why

We are not the cheapest option for Wegovy in the UK market. That is a deliberate position. One transparent price covers your consultation, prescription, treatment, next-working-day tracked delivery and seven-day priority aftercare. Nothing is added at checkout, and nothing auto-renews. Every repeat order goes back in front of a real clinician for review before it is approved and dispatched.

Our pharmacy is GPhC-registered, you can check that directly on the GPhC register, premises number 9012878. Medicines arrive through the licensed UK supply chain. Every consultation is read by a GPhC-registered Independent Prescriber, not processed by an algorithm. Our clinical team reviews the full picture: your health history, current medicines, and whether this treatment is genuinely appropriate for you at this dose.

The current treatment pricing is shown on our treatment page. What we can say here is that we don't compete on price, we compete on speed of clinical review, quality of supply and ongoing support. For more on how we approach the service, our about page sets it out plainly.

Why 'cheap' is the wrong test for a prescription medicine

The MHRA has issued repeated public warnings about fake weight-loss pens sold online, including counterfeit semaglutide products that have caused harm. Some fake pens have been found to contain insulin rather than semaglutide, a dangerous substitution with serious consequences. The pattern is consistent: sellers operating outside the regulated supply chain, often without any prescription process, offering prices well below anything a legitimate pharmacy can sustain. The MHRA's Yellow Card scheme lets you report suspected counterfeit or unsafe products if you encounter them.

For a prescription-only medicine, the cheapest listing answers the wrong question. The right question is whether the supply is genuine, whether a qualified prescriber has assessed your suitability, and whether someone with clinical knowledge is available if something concerns you during treatment. Understanding where to buy Wegovy safely means starting with verification, not price.

Red flags to know: any seller offering semaglutide without a formal prescription process, prices that sit significantly below the market range above, or 'discount codes' attached to prescription medicines from sources you cannot verify on the GPhC register. Legitimate online pharmacies are verifiable, transparent about their process, and do not need to discount prescription medicines to attract patients. If something feels off, it usually is. Anyone researching how to find cheap Wegovy through a regulated route will quickly find that the most competitive legitimate prices still include a proper prescription process, and those two things are not in conflict when you choose a regulated route. If keeping costs down is a priority, our guide on how to get Wegovy cheap without compromising on safety walks through the options available within the regulated UK market.